ARGEA Request eligibility reviewEnquire
ARGEA / Legal
Legal

Imprint, privacy and terms

Operator of this website

CompanyWYSS PERFORMANCE LLC-FZ, Dubai, United Arab Emirates
DirectorMartin Wyss, PhD
Emailcontact@argea.health
Registration[Licence number and registered address]
Responsible for contentMartin Wyss, PhD

How we handle your data

This websiteNo analytics, no tracking cookies, no advertising pixels. Fonts are loaded from Google Fonts, which receives your IP address for that request. The server keeps standard access logs for 14 days for security purposes.
Enquiry formName, email, role, country, diagnosis and message are used to answer your enquiry and for no other purpose. They are deleted twelve months after the last contact unless you become a patient.
Medical recordsRequested only after first contact, through an encrypted channel. Stored encrypted, accessible only to the physicians treating you, the coordinating team and, with your consent, your own oncologist. Never used for marketing. Never published without your written permission.
Your rightsYou can ask at any time what we hold about you, have it corrected or deleted, or withdraw consent. Write to contact@argea.health.
TransfersData may be processed in the United Arab Emirates and in the country of the partner clinic treating you: Georgia, the United Arab Emirates or Hong Kong. You are told which before consent.

Terms of use of this site

Information onlyThis site informs about a physician-led treatment programme. It is not medical advice, not an offer of treatment and not advertising for a medicine. Whether treatment is possible is decided in a medical consultation.
No approvalNGA-8000 is not authorised by the EMA, the FDA, Swissmedic or any other regulatory authority. There is no proof of efficacy from controlled trials.
AccuracyWe keep the content current and cite our sources. Science moves; if you find an error, tell us and we will correct it.
CopyrightText, diagrams and design © WYSS PERFORMANCE LLC-FZ. Cited studies belong to their authors and publishers.